Evaluating the effects of Borageseed’s oiloninflammatory in treatment of acute respiratory distress syndrome (ARDS) patients

Evaluating the effects of Borageseed’s oiloninflammatory on cytokines levels in acute respiratory distress syndrome (ARDS) patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016072420592N7

Enrollment

Registered

2017-06-05

Start date

2013-01-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome (ARDS). Severe acute respiratory syndrome [SARS], unspecified

Interventions

Intervention 1: Intervention: The patients in intervention group received 2 gr daily of Borage seed extract for 5 days. Intervention 2: Control: The patients in control group received 2 gr daily of pl

Treatment - Drugs

Intervention: The patients in intervention group received 2 gr daily of Borage seed extract for 5 days.

Control: The patients in control group received 2 gr daily of placebo for 5 days.

Eligibility

Sex/Gender

All

Age

16 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclution Criteria: Patients with acute respiratory distress syndrome. Exclution Criteria: Liver diseases; blood coagulation disorders;gastrointestinal bleeding; inflammatory bowel disease; diarrhea and other gastrointestinal malignancies under Routine treatment of inflammatory diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Interlukiun 8. Timepoint: In start of the study and 3th and 5th days. Method of measurement: Human Boster Kit.	—

Secondary

Measure	Time frame
Tumor necrosis factor alpha. Timepoint: In start of the study and 3th and 5th days. Method of measurement: Kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Mohammadreza Hashemian

Masih Daneshvari Hospital

iran.criticalcare@yahoo.com+98 21 2610 9512

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026